Skip to content

Clinical trials

Urologic Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urologic Diseases Country / region: China Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20101
20121
20151
20162
20171
20183
20201
20211
20222
20233
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting6
Unknown status3
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
argenx2
Boston Scientific Corporation1
Chang Gung Memorial Hospital1
China International Neuroscience Institution1
Chinese University of Hong Kong1
First Affiliated Hospital of Fujian Medical University1
Huazhong University of Science and Technology1
Jinling Hospital, China1
Medtronic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urologic Diseases22
Kidney Diseases9
Glomerulonephritis6
Renal Insufficiency, Chronic5
Glomerulonephritis, IGA4
Cardiovascular Diseases3
Digestive System Diseases3
Nervous System Diseases3
Endocrine System Diseases2
Immune System Diseases2

Trials

Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.